Literature DB >> 9635588

Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia.

S Takeuchi1, M Koike, T Seriu, C R Bartram, M Schrappe, A Reiter, S Park, H E Taub, I Kubonishi, I Miyoshi, H P Koeffler.   

Abstract

Cytogenetic analysis of childhood acute lymphoblastic leukemia (ALL) identified nonrandom chromosomal abnormalities of the long arm of chromosome 6. Most of the alterations are deletions that are thought to be indicative of the presence of a tumor suppressor gene that is mutated on the remaining allele. These observations led us to consider whether 6q loss may contribute to the pathogenesis of childhood ALL. To define further a region containing this gene, we analyzed the loss of heterozygosity (LOH) of chromosome 6 in 113 primary ALL samples with matched normal DNA using 34 highly informative microsatellite markers. LOH was found in 17 (15%) samples at one or more of the loci, and partial or interstitial deletions of 6q were detected in 11 of these tumors. On the basis of these results, we performed a detailed deletional map and identified two distinct regions of deletion. The first region is flanked by D6S283 and D6S302 loci at 6q21-22. The second region is flanked by D6S275 and D6S283 loci at 6q21. Clinical analysis determined that LOH of 6q was demonstrated both in precursor-B cell ALLs (15 of 93; 16%) and in T cell ALLs (2 of 19; 11%). In addition, 19 patients have been studied at diagnosis and relapse; 18 showed the same 6q21-22 structural abnormality at relapse (normal, 16 patients; LOH, 2 patients) as their initial presentation, suggesting, albeit with a small patient sample size, that 6q21-22 deletions may be an initial event in leukemogenesis and may occur less frequently during the progression of childhood ALL. These data suggest the presence of putative tumor suppressor genes on chromosome arm 6q that are important in the development of both T and precursor-B childhood ALLs. Our map provides important information toward cloning putative ALL tumor suppressor genes.

Entities:  

Mesh:

Year:  1998        PMID: 9635588

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Genetic aberrations in childhood acute lymphoblastic leukaemia: application of high-density single nucleotide polymorphism array.

Authors:  Sarina Sulong
Journal:  Malays J Med Sci       Date:  2010-07

2.  Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors.

Authors:  A Barghorn; E J Speel; B Farspour; P Saremaslani; S Schmid; A Perren; J Roth; P U Heitz; P Komminoth
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

3.  SOD2 targeted gene editing by CRISPR/Cas9 yields Human cells devoid of MnSOD.

Authors:  Kimberly Cramer-Morales; Collin D Heer; Kranti A Mapuskar; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2015-07-21       Impact factor: 7.376

4.  Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.

Authors:  Jeong A Park; Kyung Ran Jun; So Hyun Nam; Thad T Ghim
Journal:  Int J Hematol       Date:  2013-04-04       Impact factor: 2.490

5.  Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.

Authors:  Almut Bokemeyer; Cornelia Eckert; Franziska Meyr; Gabriele Koerner; Arend von Stackelberg; Reinhard Ullmann; Seval Türkmen; Günter Henze; Karl Seeger
Journal:  Haematologica       Date:  2013-11-15       Impact factor: 9.941

6.  Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3.

Authors:  Y Utada; S Haga; T Kajiwara; F Kasumi; G Sakamoto; Y Nakamura; M Emi
Journal:  Jpn J Cancer Res       Date:  2000-03

7.  The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategies.

Authors:  C H Borchers; J Kast; L J Foster; K W M Siu; C M Overall; T A Binkowski; W H Hildebrand; A Scherer; M Mansoor; P A Keown
Journal:  J Proteomics       Date:  2013-08-08       Impact factor: 4.044

Review 8.  Prognostic relevance of genetic variations in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.

Authors:  Hui Yu; Yuxin Du; Ji Xu; Mingzhi Zhang
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.